Top View
- CCN3: a Key Growth Regulator in Chronic Myeloid Leukaemia
- Tyrosine Phosphorylation of Grb2 by Bcr/Abl and Epidermal Growth Factor Receptor: a Novel Regulatory Mechanism for Tyrosine Kinase Signaling
- Rhoa: a Therapeutic Target for Chronic Myeloid Leukemia Molli Et Al
- Guanine Nucleotide Exchange Factors for Rho Gtpases: Turning on the Switch
- Leukemia BCR-ABL Fusion Gene Typing Real Time RT-PCR Kit User
- Grb2) Expands Myeloid Cells
- NOV Gene Expression in Human Prostate Cancer Is Directly Suppressed by the Androgen Receptor
- Paxillin Interactions
- Depends on the SHIP Inositol Phosphatase to B Cell Antigen
- Figure S1. Protein‑Protein Interaction Predicted by STRING of Confirmed Differentially Expressed Genes, KRAS and AKT
- Class Effects of Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia
- Rhoa As a Key Regulator of Innate and Adaptive Immunity
- The Tyrosine Kinase Inhibitor CGP 57148 (ST1 571) Induces Apoptosis in BCR-ABL-Positive Cells by Down-Regulating BCL-X1
- BCR/ABL Genes and Leukemic Phenotype: from Molecular Mechanisms to Clinical Correlations
- Fc Gamma Receptor Iib Modulates the Molecular Grb2 Interaction Network in Activated B Cells
- Rewiring of B Cell Receptor Signaling by Epstein–Barr Virus LMP2A
- BD BCR-ABL Protein Kit for Determining BCR-ABL Fusion Proteins
- Bcr Phosphorylated on Tyrosine 177 Binds Grb2
- Bulk BCR Technical V2
- SHP-1 Is Directly Activated by the Aryl Hydrocarbon Receptor and Regulates BCL-6 in the Presence of 2,3,7,8-Tetrachlorodibenzo-P-Dioxin (TCDD)
- Grb10 Is a Dual Regulator of Receptor Tyrosine Kinase Signaling
- Leukemia BCR-ABL Fusion Gene (M-BCR) Real Time RT-PCR Kit 8
- [Frontiers in Bioscience 9, 387-403, January 1, 2004] 387 GRB10
- Activation of FIP1L1-PDGFR Requires Disruption of the Juxtamembrane
- A 76-Kb Duplicon Maps Close to the BCR Gene on Chromosome 22 and the ABL Gene on Chromosome 9: Possible Involvement in the Genes
- Growth of Chronic Myeloid Leukemia Cells Is Inhibited by Infection with Ad-SH2-HA Adenovirus That Disrupts Grb2-Bcr-Abl Complexes
- On Oncogenic Activation (Abelson Leukemia Virus/Hardy-Zuckerman Feline Sarcoma Virus/Protein Kinase) SCOTT K
- Molecular Basis for the Actions of Hsp90 Inhibitors and Cancer Therapy
- BCR-ABL 1 Testing AHS – M2027
- Anti-Phospho-Paxillin (Ptyr181)
- Enhanced BCR Signaling Inflicts Early Plasmablast and Germinal Center B
- Finding Concensus After Two Decades of BIA Anaplastic Large Cell
- Ipsogen® BCR-ABL1 Mbcr Kit Handbook
- BCR/ABL Induces Multiple Abnormalities of Cytoskeletal Function
- SHP-1 (PTPN6) Keeps the Inflammation at Bay: Limiting IL
- Modified SH2 Domain to Phototrap and Identify Phosphotyrosine
- HHS Public Access Author Manuscript
- Treatment for Chronic Myelogenous Leukemia: the Long Road to Imatinib Tony Hunter
- Elucidating the Transcriptional Program of Feline Injection-Site Sarcoma Using a Cross- Species Mrna-Sequencing Approach Qi Wei1†, Stephen A
- Phosphorylation of BECLIN-1 by BCR-ABL Suppresses Autophagy in Chronic Myeloid Leukemia
- The SH2-Containing Adapter Protein GRB10 Interacts with BCR-ABL
- Grb10 Is Involved in BCR-ABL-Positive Leukemia in Mice
- Grb10 Is a Dual Regulator of Receptor Tyrosine Kinase Signaling Kabir
- Loss of the BCR-FGFR1 GEF Domain Suppresses
- Loss of the BCR-FGFR1 GEF Domain Suppresses RHOA Activation and Enhances B-Lymphomagenesis In
- Molecular Pathways: BCR-ABL
- Imatinib Mesylate (Gleevec) Inhibits Ovarian Cancer Cell Growth Through a Mechanism Dependent on Platelet-Derived Growth Factor Receptor ␣ and Akt Inactivation
- Bcr/Abl Associated Leukemogenesis in Bcr Null Mutant Mice
- Oncogenic Fusion Protein BCR-FGFR1 Requires The
- Anti-Phospho-Paxillin [Ptyr31] Developed in Rabbit, Affinity Isolated Antibody
- BCR/ABL T(9;22), P210 Kd
- Delayed Diagnosis Leading to Accelerated-Phase Chronic Eosinophilic Leukemia Due to a Cytogenetically Cryptic, Imatinib-Responsive TNIP1–PDFGRB Fusion Gene
- BCR-ABL P190 (Mbcr) One-Step Detection Kit
- Genetic Screening for Potential New Targets in Chronic Myeloid Leukemia Based on Drosophila Transgenic for Human BCR-ABL1